{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:05:50Z","timestamp":1751601950430,"version":"3.41.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023YFS0173","2022YFS0135"],"award-info":[{"award-number":["2023YFS0173","2022YFS0135"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020207","name":"Health Commission of Sichuan Province","doi-asserted-by":"publisher","award":["SCR2023-210"],"award-info":[{"award-number":["SCR2023-210"]}],"id":[{"id":"10.13039\/501100020207","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02555-y","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T12:37:20Z","timestamp":1740400640000},"page":"1415-1431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Causes of death in patients with malignant adrenal tumours: a population-based analysis"],"prefix":"10.1007","volume":"48","author":[{"given":"Yang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunlin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shida","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangqing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"issue":"2","key":"2555_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/er.2002-0031","volume":"25","author":"G Mansmann","year":"2004","unstructured":"Mansmann G, Lau J, Balk E et al (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25(2):309\u2013340","journal-title":"Endocr Rev"},{"issue":"1","key":"2555_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/CCO.0000000000000799","volume":"34","author":"S Grisanti","year":"2022","unstructured":"Grisanti S, Cosentini D, Sigala S et al (2022) Molecular genotyping of adrenocortical carcinoma: A systematic analysis of published literature 2019\u20132021. Current Opinion in Oncology 34(1):19\u201328","journal-title":"Current Opinion in Oncology"},{"issue":"1","key":"2555_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0889-8529(05)70113-4","volume":"29","author":"CA Stratakis","year":"2000","unstructured":"Stratakis CA, Chrousos GP (2000) Adrenal cancer. Endocrinol Metab Clin North Am 29(1):15\u201325 vii-viii","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"11","key":"2555_CR4","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1016\/j.ejca.2013.02.034","volume":"49","author":"TM Kerkhofs","year":"2013","unstructured":"Kerkhofs TM, Verhoeven RH, Van der Zwan JM et al (2013) Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. Eur J Cancer 49(11):2579\u20132586","journal-title":"Eur J Cancer"},{"issue":"11","key":"2555_CR5","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","volume":"31","author":"M Fassnacht","year":"2020","unstructured":"Fassnacht M, Assie G, Baudin E et al (2020) Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(11):1476\u20131490","journal-title":"Ann Oncol"},{"issue":"2","key":"2555_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ncpendmet0396","volume":"3","author":"K Pacak","year":"2007","unstructured":"Pacak K, Eisenhofer G, Ahlman H et al (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab. 3(2):92\u2013102","journal-title":"Nat Clin Pract Endocrinol Metab."},{"issue":"Suppl 7","key":"2555_CR7","doi-asserted-by":"publisher","first-page":"vii131","DOI":"10.1093\/annonc\/mds231","volume":"23","author":"A Berruti","year":"2012","unstructured":"Berruti A, Baudin E, Gelderblom H et al (2012) Adrenal cancer: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii131\u2013vii138","journal-title":"Ann Oncol"},{"issue":"3","key":"2555_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/jc.2010-1946","volume":"96","author":"M Ayala-Ramirez","year":"2011","unstructured":"Ayala-Ramirez M, Feng L, Johnson MM et al (2011) Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab 96(3):717\u2013725","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"2555_CR9","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1002\/cncr.28813","volume":"120","author":"JR Musselman","year":"2014","unstructured":"Musselman JR, Spector LG, Krailo MD et al (2014) The Children\u2019s Oncology Group Childhood Cancer Research Network (CCRN): case catchment in the United States. Cancer 120(19):3007\u20133015","journal-title":"Cancer"},{"issue":"6","key":"2555_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","volume":"18","author":"E Steliarova-Foucher","year":"2017","unstructured":"Steliarova-Foucher E, Colombet M, Ries LAG et al (2017) International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol 18(6):719\u2013731","journal-title":"Lancet Oncol"},{"key":"2555_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.critrevonc.2016.10.001","volume":"107","author":"R Luksch","year":"2016","unstructured":"Luksch R, Castellani MR, Collini P et al (2016) Neuroblastoma (peripheral neuroblastic tumours). Crit Rev Oncol Hematol 107:163\u2013181","journal-title":"Crit Rev Oncol Hematol"},{"issue":"13","key":"2555_CR12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.2174\/1389200221666191226102231","volume":"20","author":"S Mallepalli","year":"2019","unstructured":"Mallepalli S, Gupta MK, Vadde R (2019) Neuroblastoma: An Updated Review on Biology and Treatment. Curr Drug Metab 20(13):1014\u20131022","journal-title":"Curr Drug Metab"},{"issue":"7","key":"2555_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1136\/jcp.2007.050625","volume":"61","author":"M Volante","year":"2008","unstructured":"Volante M, Buttigliero C, Greco E et al (2008) Pathological and molecular features of adrenocortical carcinoma: an update. J Clin Pathol 61(7):787\u2013793","journal-title":"J Clin Pathol"},{"issue":"6","key":"2555_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrendo.2010.235","volume":"7","author":"M Fassnacht","year":"2011","unstructured":"Fassnacht M, Lib\u00e9 R, Kroiss M et al (2011) Adrenocortical carcinoma: a clinician\u2019s update. Nat Rev Endocrinol 7(6):323\u2013335","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"2555_CR15","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1210\/jc.2007-0709","volume":"92","author":"L Amar","year":"2007","unstructured":"Amar L, Baudin E, Burnichon N et al (2007) Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab 92(10):3822\u20133828","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2555_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.urolonc.2009.11.005","volume":"30","author":"E Scosyrev","year":"2012","unstructured":"Scosyrev E, Messing J, Noyes K et al (2012) Surveillance epidemiology and end results (SEER) program and population-based research in urologic oncology: an overview. Urol Oncol 30(2):126\u2013132","journal-title":"Urol Oncol"},{"issue":"8 Suppl","key":"2555_CR17","first-page":"Iv","volume":"40","author":"JL Warren","year":"2002","unstructured":"Warren JL, Klabunde CN, Schrag D et al (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl):Iv\u20133","journal-title":"Med Care"},{"issue":"8","key":"2555_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/jnci\/92.8.613","volume":"92","author":"CJ Newschaffer","year":"2000","unstructured":"Newschaffer CJ, Otani K, McDonald MK et al (2000) Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst 92(8):613\u2013621","journal-title":"J Natl Cancer Inst"},{"issue":"30","key":"2555_CR19","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1200\/JCO.2010.32.6462","volume":"29","author":"E Colzani","year":"2011","unstructured":"Colzani E, Liljegren A, Johansson AL et al (2011) Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics. J Clin Oncol 29(30):4014\u20134021","journal-title":"J Clin Oncol"},{"issue":"4","key":"2555_CR20","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","volume":"179","author":"M Fassnacht","year":"2018","unstructured":"Fassnacht M, Dekkers OM, Else T et al (2018) European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the study of adrenal tumors. Eur J Endocrinol 179(4):G1\u2013G46","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2555_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","volume":"28","author":"AK Lam","year":"2017","unstructured":"Lam AK (2017) Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocr Pathol 28(3):213\u2013227","journal-title":"Endocr Pathol"},{"issue":"6","key":"2555_CR22","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMra1806651","volume":"381","author":"HPH Neumann","year":"2019","unstructured":"Neumann HPH, Young WF Jr., Eng C (2019) Pheochromocytoma and Paraganglioma. N Engl J Med 381(6):552\u2013565","journal-title":"N Engl J Med"},{"key":"2555_CR23","doi-asserted-by":"publisher","first-page":"175030","DOI":"10.1016\/j.ejphar.2022.175030","volume":"926","author":"F Salemi","year":"2022","unstructured":"Salemi F, Alam W, Hassani MS et al (2022) Neuroblastoma: Essential genetic pathways and current therapeutic options. Eur J Pharmacol 926:175030","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2555_CR24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/annonc\/mdw604","volume":"28","author":"NG Zaorsky","year":"2017","unstructured":"Zaorsky NG, Churilla TM, Egleston BL et al (2017) Causes of death among cancer patients. Ann Oncol 28(2):400\u2013407","journal-title":"Ann Oncol"},{"issue":"4","key":"2555_CR25","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ijrobp.2015.11.046","volume":"94","author":"PD Inskip","year":"2016","unstructured":"Inskip PD, Sigurdson AJ, Veiga L et al (2016) Radiation-Related New Primary Solid cancers in the Childhood Cancer Survivor Study: comparative Radiation Dose Response and Modification of Treatment effects. Int J Radiat Oncol Biol Phys 94(4):800\u2013807","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"23","key":"2555_CR26","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1182\/blood-2014-05-579193","volume":"124","author":"AK Ng","year":"2014","unstructured":"Ng AK (2014) Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects. Blood 124(23):3373\u20133379","journal-title":"Blood"},{"issue":"7","key":"2555_CR27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00066-015-0837-z","volume":"191","author":"A Ducassou","year":"2015","unstructured":"Ducassou A, Gambart M, Munzer C et al (2015) Long-term side effects of radiotherapy for pediatric localized neuroblastoma: results from clinical trials NB90 and NB94. Strahlenther Onkol 191(7):604\u2013612","journal-title":"Strahlenther Onkol"},{"issue":"7","key":"2555_CR28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/jnci\/djt014","volume":"105","author":"CL Wilson","year":"2013","unstructured":"Wilson CL, Ness KK, Neglia JP et al (2013) Renal carcinoma after childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 105(7):504\u2013508","journal-title":"J Natl Cancer Inst"},{"key":"2555_CR29","doi-asserted-by":"crossref","unstructured":"Westerveld ASR, van Dalen EC, Asogwa OA et al (2022) Neuroblastoma survivors at risk for developing subsequent neoplasms: A systematic review. Cancer Treat Rev. 104(102355)","DOI":"10.1016\/j.ctrv.2022.102355"},{"issue":"11","key":"2555_CR30","first-page":"2885","volume":"51","author":"MA Tucker","year":"1991","unstructured":"Tucker MA, Jones PH, Boice JD Jr. et al (1991) Therapeutic radiation at a young age is linked to secondary thyroid cancer. The late effects Study Group. Cancer Res 51(11):2885\u20132888","journal-title":"Cancer Res"},{"issue":"5","key":"2555_CR31","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/ijc.11455","volume":"107","author":"C Rubino","year":"2003","unstructured":"Rubino C, Adjadj E, Gu\u00e9rin S et al (2003) Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment. Int J Cancer 107(5):791\u2013796","journal-title":"Int J Cancer"},{"issue":"9","key":"2555_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.urolonc.2015.05.002","volume":"33","author":"SA Curreri","year":"2015","unstructured":"Curreri SA, Fung C, Beard CJ (2015) Secondary malignant neoplasms in testicular cancer survivors. Urol Oncol 33(9):392\u2013398","journal-title":"Urol Oncol"},{"issue":"1","key":"2555_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1573396313666161114233135","volume":"13","author":"R Kebudi","year":"2017","unstructured":"Kebudi R, Ozdemir GN (2017) Secondary Neoplasms in Children Treated for Cancer. Curr Pediatr Rev 13(1):34\u201341","journal-title":"Curr Pediatr Rev"},{"issue":"21","key":"2555_CR34","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1200\/JCO.2017.76.7764","volume":"36","author":"LM Turcotte","year":"2018","unstructured":"Turcotte LM, Neglia JP, Reulen RC et al (2018) Risk, risk factors, and Surveillance of subsequent malignant neoplasms in survivors of Childhood Cancer: a review. J Clin Oncol 36(21):2145\u20132152","journal-title":"J Clin Oncol"},{"issue":"5","key":"2555_CR35","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/cncr.29096","volume":"121","author":"S Bhatia","year":"2015","unstructured":"Bhatia S (2015) Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors. Cancer 121(5):648\u2013663","journal-title":"Cancer"},{"key":"2555_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejca.2016.11.022","volume":"72","author":"MA Applebaum","year":"2017","unstructured":"Applebaum MA, Vaksman Z, Lee SM et al (2017) Neuroblastoma survivors are at increased risk for second malignancies: a report from the International Neuroblastoma Risk Group Project. Eur J Cancer 72:177\u2013185","journal-title":"Eur J Cancer"},{"key":"2555_CR37","doi-asserted-by":"crossref","unstructured":"Barr EK and Applebaum\u00a0MA (2018) Genetic Predisposition to Neuroblastoma. Children (Basel). 5(9)","DOI":"10.3390\/children5090119"},{"issue":"7\u20138 Pt 2","key":"2555_CR38","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/j.lpm.2018.07.004","volume":"47","author":"EJ Petr","year":"2018","unstructured":"Petr EJ, Else T (2018) Adrenocortical carcinoma (ACC): When and why should we consider germline testing? Presse Med 47(7\u20138 Pt 2):e119\u2013e125","journal-title":"Presse Med"},{"issue":"1","key":"2555_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mce.2011.12.008","volume":"351","author":"T Else","year":"2012","unstructured":"Else T (2012) Association of adrenocortical carcinoma with familial cancer susceptibility syndromes. Mol Cell Endocrinol 351(1):66\u201370","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"2555_CR40","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10552-010-9521-x","volume":"21","author":"DW Shin","year":"2010","unstructured":"Shin DW, Ahn E, Kim H et al (2010) Non-cancer mortality among long-term survivors of adult cancer in Korea: national cancer registry study. Cancer Causes Control 21(6):919\u2013929","journal-title":"Cancer Causes Control"},{"issue":"3","key":"2555_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jaccao.2020.06.004","volume":"2","author":"AC Cameron","year":"2020","unstructured":"Cameron AC, McMahon K, Hall M et al (2020) Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer. JACC CardioOncol 2(3):443\u2013455","journal-title":"JACC CardioOncol"},{"issue":"6","key":"2555_CR42","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1378\/chest.129.6.1432","volume":"129","author":"PA Danai","year":"2006","unstructured":"Danai PA, Moss M, Mannino DM et al (2006) The epidemiology of sepsis in patients with malignancy. Chest 129(6):1432\u20131440","journal-title":"Chest"},{"issue":"3","key":"2555_CR43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jcrc.2011.06.014","volume":"27","author":"MM Rosolem","year":"2012","unstructured":"Rosolem MM, Rabello LS, Lisboa T et al (2012) Critically ill patients with cancer and sepsis: clinical course and prognostic factors. J Crit Care 27(3):301\u2013307","journal-title":"J Crit Care"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02555-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02555-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02555-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:03:36Z","timestamp":1751540616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02555-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2555"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02555-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"14 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All data were obtained from the public database; no ethical approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval"}}]}}